According to court filings reported by USA Today, the breakdown of allegations in the GI litigation includes: 75% allege gastroparesis (stomach paralysis) 18% allege ileus (bowel dysfunction) 18% allege intestinal obstructions 8% allege gallbladder injuries requiring surgery 110+ plaintiffs allege sudden blindness or severe vision changes Traditional Approach vs LlamaLab Solution Traditional Approach Delayed Warnings Label updates came years after adverse events emerged in clinical use Generic GI Warnings Labels mentioned nausea and vomiting but not severe gastroparesis risk No U.S
Bydureon Bcise (exenatide) used to help control blood sugar levels in patients with type 2 diabetes Tanzeum (albiglutide) used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Byetta (exenatide) also used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Mounjaro (tirzepatide) a once-weekly glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, the only FDA-approved dual-action GIP and GLP-1 receptor agonist for the treatment of diabetes Which GLP-1 works best for weight loss
Trust Deeds can be recorded in first, second, or third lien position
Barbadoro P, Annino I, Ponzio E, Romanelli RM, DErrico MM, Prospero E, et al
Patients rate the prescribing flexibility and physician knowledge highly, with common praise for willingness to prescribe hCG and to discuss peptides openly
the test does not predict your response to a specific medication or determine which one you should take
